Indicaton
Third line Follicular Lymphoma patients who are refractory to anti-CD20 based therapy
- Leave a review
- Bookmark
- Share
- Report
- prev
- next
Table
-
PhasePhase II started
-
Partnering statusNot partnered
You may also be interested in
SOT201 (Immunocytokine, PD-1 x IL-15) 
-
solid tumors
Phase I started
SOT109 (Antibody-Drug Conjugate)
-
solid tumors, mainly colorectal
Discovery